- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 204-218 of
1,115 results
USE OF A VEGF ANTAGONIST TO TREAT ANGIOGENIC EYE DISORDERS
Docket
17/352,892,
U.S. Patent Application
(June 21, 2021)
|
|
Cite Docket
24 Motion PHV: Motion Pro Hac Vice Elliot Choi
Document
IPR2023-00884, No. 24 Motion PHV - Motion Pro Hac Vice Elliot Choi (P.T.A.B. Jan. 4, 2024)
|
|
Cite Document
23 Motion PHV: Motion Pro Hac Vice Zachriah Summers
Document
IPR2023-00884, No. 23 Motion PHV - Motion Pro Hac Vice Zachriah Summers (P.T.A.B. Jan. 4, 2024)
|
|
Cite Document
20 Motion PHV: Motion Pro Hac Vice Daralyn J Durie
Document
IPR2023-00884, No. 20 Motion PHV - Motion Pro Hac Vice Daralyn J Durie (P.T.A.B. Dec. 21, 2023)
|
|
Cite Document
19 Motion PHV: Motion Pro Hac Vice Kira A Davis
Document
IPR2023-00884, No. 19 Motion PHV - Motion Pro Hac Vice Kira A Davis (P.T.A.B. Dec. 21, 2023)
|
|
Cite Document
No. 124
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 124 (N.D.W.Va. Nov. 29, 2022)
|
|
Cite Document
No. 102
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 102 (N.D.W.Va. Nov. 17, 2022)
|
|
Cite Document
No. 90
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 90 (N.D.W.Va. Nov. 2, 2022)
|
|
Cite Document
No. 88
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 88 (N.D.W.Va. Oct. 28, 2022)
|
|
Cite Document
68 Other other: Petitioners Request for Oral Argument
Document
IPR2023-00884, No. 68 Other other - Petitioners Request for Oral Argument (P.T.A.B. Jul. 8, 2024)
|
|
Cite Document
No. 85
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 85 (N.D.W.Va. Oct. 20, 2022)
|
|
Cite Document
67 Notice Other: Joint Notice of Stipulation to Modify Due Date 3
Document
IPR2023-00884, No. 67 Notice Other - Joint Notice of Stipulation to Modify Due Date 3 (P.T.A.B. Jun. 28, 2024)
|
|
Cite Document
66 Other other: Patent Owner’s Objections to Evidence Submitted with Petitioner’s...
Document
IPR2023-00884, No. 66 Other other - Patent Owner’s Objections to Evidence Submitted with Petitioner’s Reply to Patent Owner’s Response (P.T.A.B. Jun. 17, 2024)
|
|
Cite Document
No. 78
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 78 (N.D.W.Va. Sep. 29, 2022)
|
|
Cite Document
No. 77
Document
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc., 1:22-cv-00061, No. 77 (N.D.W.Va. Sep. 29, 2022)
|
|
Cite Document
